{"url_path":"/sec/ahco/8-k/2026-07-20/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-20","source_url":"https://www.sec.gov/Archives/edgar/data/1725255/0001104659-26-085086-index.html","accession_number":"0001104659-26-085086","cik":"0001725255","ticker":"AHCO","issuer_name":"AdaptHealth Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1725255/0001104659-26-085086-index.html","primary_entity_key":"0001725255","primary_entity_name":"AdaptHealth Corp."},"word_count":299,"has_tables":true,"body_markdown":"false\n0001725255\n\n0001725255\n\n2026-07-19\n2026-07-19\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\n \n\n \n\n \n\n**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n \n\n \n\n**FORM 8-K**\n\n \n\n \n\n**CURRENT REPORT**\n\n**Pursuant to Section 13 or 15(d)**\n\n**of the Securities Exchange Act of 1934**\n\n** **\n\n**July 19, 2026**\n\n**Date of Report (date\nof earliest event reported)**\n\n \n\n**AdaptHealth Corp.**\n\n**(Exact name of registrant as specified in its\ncharter)**\n\n \n\nDelaware \n001-38399 \n82-3677704\n\n**(State\nor other jurisdiction of incorporation or organization**)** **\n**(Commission\nFile Number)**** **\n**(I.R.S. Employer Identification Number)**\n\n \n\n**555 East North Lane****, Suite 5075,** **Conshohocken****, PA** **19428**\n\n**(Address\nof principal executive offices and zip code)**\n\n** \n   **\n\n**(610****)\n424-4515**\n\n**(Registrant’s\ntelephone number, including area code)**\n\n**  **\n\n**Check the appropriate box below if the Form\n8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:**\n\n** **\n\n**¨****Written\ncommunications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)**\n\n ** **\n\n**¨****Soliciting\nmaterial pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)**\n\n ** **\n\n**¨****Pre-commencement\ncommunications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))**\n\n ** **\n\n**¨****Pre-commencement\ncommunications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))**\n\n** **\n\n**Securities registered pursuant\nto Section 12(b) of the Act:**\n\n** **\n\n**Title\nof each class**\n** **\n**Trading \nSymbol**\n** **\n**Name of each\nexchange on which\nregistered**\n\n**Common\nStock, par value $0.0001 per share**\n** **\n**AHCO**\n** **\n**The\nNasdaq Stock Market LLC**\n\n** **\n\n**Indicate by check mark whether the registrant\nis an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2\nof the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).**\n\n** **\n\n**Emerging growth\ncompany****¨**\n\n** **\n\n**If an emerging\ngrowth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any\nnew or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨**"}